Prestige Consumer Healthcare (PBH) Receivables - Net (2016 - 2025)
Prestige Consumer Healthcare has reported Receivables - Net over the past 15 years, most recently at $190.5 million for Q4 2025.
- Quarterly results put Receivables - Net at $190.5 million for Q4 2025, up 13.86% from a year ago — trailing twelve months through Dec 2025 was $190.5 million (up 13.86% YoY), and the annual figure for FY2025 was $194.3 million, up 9.91%.
- Receivables - Net for Q4 2025 was $190.5 million at Prestige Consumer Healthcare, down from $199.0 million in the prior quarter.
- Over the last five years, Receivables - Net for PBH hit a ceiling of $199.0 million in Q3 2025 and a floor of $114.7 million in Q1 2021.
- Median Receivables - Net over the past 5 years was $161.0 million (2023), compared with a mean of $160.1 million.
- Biggest five-year swings in Receivables - Net: dropped 23.82% in 2021 and later grew 21.68% in 2025.
- Prestige Consumer Healthcare's Receivables - Net stood at $134.3 million in 2021, then increased by 17.0% to $157.1 million in 2022, then increased by 10.95% to $174.3 million in 2023, then fell by 4.02% to $167.3 million in 2024, then rose by 13.86% to $190.5 million in 2025.
- The last three reported values for Receivables - Net were $190.5 million (Q4 2025), $199.0 million (Q3 2025), and $168.4 million (Q2 2025) per Business Quant data.